Hosted on MSN1mon
H.C. Wainwright maintains Buy on OKYO Pharma with $7 targetThese results from the DED trial suggest that OK-101 could be an effective solution for reducing the pain associated with NCP. With these findings in mind, H.C. Wainwright has reaffirmed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback